Why has the American sunscreen market been stuck in a decades-long innovation drought?

The US sunscreen market lags behind global standards due to regulatory hurdles. This episode examines the FDA's slow approval process for new ingredients and explores a legislative proposal aimed at accelerating innovation, featuring the story of a skincare influencer who campaigned for reform.

For nearly thirty years, the Food and Drug Administration did not approve a single new sunscreen ingredient, leaving American consumers with fewer options than those available elsewhere in the world. The agency has only recently authorized its first new ingredient in this timeframe.

The discussion highlights the tension between safety regulation and the need for modern skincare technology. By looking at a specific proposal to expedite the approval of sunscreen and drug innovations, the episode illustrates how public advocacy—including the efforts of a skincare influencer—can influence the regulatory landscape.

Source: Why doesn't the US have better sunscreen? | The Indicator